EP
MIRM icon

Eversept Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Eversept Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,314
Closed -$3.62M – 113
2025
Q3 		$3.62M Sell
49,314
-182,861
-79% -$11.6M 0.25% 56
2025
Q2 		$11.8M Buy
+232,175
New +$10.3M 1.09% 28

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Eversept Partners's MIRM Position: Q4 2025 in Review

Eversept Partners sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 49,314 shares — an estimated $3.62M sold.

Eversept Partners first reported a position in MIRM in Q2 2025 and held it in 2 quarters. The position peaked at $11.8M in Q2 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Eversept Partners reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Eversept Partners sold 49,314 Mirum Pharmaceuticals shares in Q4 2025, an estimated $3.62M.
  • Eversept Partners first reported a position in Mirum Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Eversept Partners's Mirum Pharmaceuticals position peaked at $11.8M in Q2 2025.
  • 281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Eversept Partners's 13F filing for Q4 2025, filed 17 Feb 2026.